Chinese University of Hong Kong, Take2 Sue Pacific Biosciences Over DNA Methylation Detection Tech
The Hong Kong-based plaintiffs alleged that PacBio has copied their method of calling methylated bases using quirks of the PacBio sequencing method.
Ravgen NIPT Patents Withstand Illumina Challenge
The US Patent Trial and Appeal Board delivered a pair of rulings stating that Illumina failed to show Ravgen's innovations should be considered unpatentable.
Proove Biosciences CEO Exonerated in PGx Test Kickback Case
Proove's founder and CEO was indicted last year on charges the company had defrauded Medicare and violated the Anti-Kickback Statute by paying physicians to use its pharmacogenetic tests.
Top 10 Articles on GenomeWeb in 2022: Illumina, Invitae, 10x Genomics, Natera, Element, Ultima, More
Over the past year, GenomeWeb readers were most interested in layoffs at genomics companies, Illumina's business, and new sequencing technology firms.
Natera Files Second Patent Infringement Suit Against NeoGenomics Subsidiary Inivata
The suit was filed the same day Natera received a new patent covering its patient-specific residual cancer testing and monitoring methods.